Two separate differentiation inducing proteins for human myeloid leukemia cells and their isolation from normal

M Abolhassani1, W M Riley, E Feldman

  • 1Department of Medicine, New York Medical College, Valhalla 10595.

Insights

Normal lymphocytes contain a maturation inducer that differentiates leukemia cells. This inducer, a 54 kDa protein, is less abundant in acute myelogenous leukemia patients, suggesting a role in leukemia cell differentiation.

Area of Science:

  • Immunology
  • Cell Biology
  • Hematology

Background:

  • Peripheral blood lymphocytes (PBL) conditioned medium contains activity promoting myeloid leukemia cell differentiation.
  • This activity induces differentiation of human myeloid leukemia cells into monocytes and macrophages.

Purpose of the Study:

  • To isolate and characterize the maturation inducer activity from stimulated normal PBL.
  • To investigate the role of this inducer in acute myelogenous leukemia (AML).

Main Methods:

  • Isolation of maturation inducer activity using salt precipitation, chromatography (Sepharose CL-6B ion exchange and affinity), and electrophoresis.
  • Characterization of molecular weight (MW) and identification using ELISA and differentiation blocking assays.
  • Detection of the 54 kDa protein on PBL surface membranes via immunofluorescent antibody technique.

Main Results:

  • Two distinct MW activities (52-56 kDa and 32-35 kDa) were identified, mediating HL-60 promyelocyte differentiation.
  • The higher MW species was identified as a 54 kDa polypeptide, distinct from IL-3 and IL-6.
  • The 32-35 kDa activity was neutralized by anti-IL-3 antibodies.
  • Significantly lower proportions and numbers of maturation inducer-bearing lymphocytes were found in AML patients compared to healthy donors.

Conclusions:

  • A 54 kDa protein on PBL surface membranes acts as a maturation inducer for myeloid leukemia cells.
  • Reduced levels of this inducer in AML patients suggest its potential role in impaired leukemia cell differentiation.
  • Further research into these physiological factors could offer insights into leukemia treatment strategies.